Free Trial
LON:TRS

Tarsus Group (TRS) Share Price, News & Analysis

Tarsus Group logo

About Tarsus Group Stock (LON:TRS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
215,764 shs
Average Volume
272,972 shs
Market Capitalization
£549.84 million
P/E Ratio
45.59
Dividend Yield
2.59%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tarsus Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRS Stock News Headlines

Tarsus Stock Price History
Tarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
Earnings Outlook For Tarsus Pharmaceuticals
TRS Yucatan Hotel
See More Headlines

TRS Stock Analysis - Frequently Asked Questions

Shares of TRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tarsus Group investors own include Avery Dennison (AVY), Aviva (AV), Fidelity Japan Trust (FJV), Hotel Chocolat Group (HOTC), HSBC (HSBA), Primary Health Properties (PHP) and

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Advertising Agencies
Sub-Industry
Fabricated Products
Current Symbol
LON:TRS
CIK
N/A
Fax
N/A
Employees
3,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
45.59
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
105.77
Current Ratio
0.72
Quick Ratio
0.55

Sales & Book Value

Annual Sales
£99.73 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
19.27
Book Value
GBX 77.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
129,679,000
Free Float
N/A
Market Cap
£549.84 million
Optionable
Not Optionable
Beta
N/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:TRS) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners